These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17849796)

  • 1. [Clinical effects of metformin in patients with polcystic ovarian syndrome].
    Galindo CG; Hernández I; Ayala AR
    Ginecol Obstet Mex; 2007 Apr; 75(4):181-6. PubMed ID: 17849796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
    Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Kavŭrdzhikova S
    Akush Ginekol (Sofiia); 2006; 45(6):29-35. PubMed ID: 17168480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
    Qublan HS; Yannakoula EK; Al-Qudah MA; El-Uri FI
    Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].
    Ma LK; Jin LN; Yu Q; Xu L
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):294-7. PubMed ID: 17673038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):209-13. PubMed ID: 15653205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS; Zaino RJ; Demers LM; Kunselman AR; Gnatuk CL; Williams NI; Dodson WC
    Am J Obstet Gynecol; 2007 Apr; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment experience with metformin in polycystic ovary syndrome].
    Petrányi G
    Orv Hetil; 2005 May; 146(21):1151-5. PubMed ID: 15991679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
    Meyer C; McGrath BP; Teede HJ
    Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
    Bridger T; MacDonald S; Baltzer F; Rodd C
    Arch Pediatr Adolesc Med; 2006 Mar; 160(3):241-6. PubMed ID: 16520442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin therapy in women with polycystic ovary syndrome.
    Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
    Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.